The effects of human leukocyte antigen DRB113 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy womenResearch in Context

Background: Age-related brain changes are well-documented and influenced by genetics. Extensive research links apolipoprotein E (apoE) to brain function, with the E4 allele serving as a risk factor for brain disease, including Alzheimer's disease, and the E2 allele conferring protection. Recent...

Full description

Saved in:
Bibliographic Details
Published inEBioMedicine Vol. 35; pp. 288 - 294
Main Authors Lisa M. James, Stacy Dolan, Arthur C. Leuthold, Brian E. Engdahl, Angeliki Georgopoulos, Apostolos P. Georgopoulos
Format Journal Article
LanguageEnglish
Published Elsevier 01.09.2018
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Age-related brain changes are well-documented and influenced by genetics. Extensive research links apolipoprotein E (apoE) to brain function, with the E4 allele serving as a risk factor for brain disease, including Alzheimer's disease, and the E2 allele conferring protection. Recent evidence also supports protective effects of another gene, human leukocyte antigen (HLA) DRB1*13, on brain disease and age-related brain atrophy in cognitively healthy adults. Here we investigated the effects of apoE and HLA DRB1*13 on brain function by examining changes in neural network properties with age in healthy adults. Methods: One hundred seventy-eight cognitively healthy women (28–99 y old) underwent a magnetoencephalography scan and provided a blood sample for genetic analysis. Age-related changes in neural network variability in genetic subgroups of DRB1*13 × apoE genotype combinations were assessed using linear regression of network variability against age. Findings: For individuals lacking a DRB1*13 allele and/or carrying an apoE4 allele, network variability increased significantly with age. In contrast, no such increase was observed in the presence of DRB1*13 and/or apoE2. Interpretation: These findings extend previous research documenting the protective effect of DRB1*13 on brain structure to include protection against age-related changes in brain function, and demonstrate similar protective effects on neural network variability for either DRB1*13 or apoE2. These protective effects could be due to reduction or elimination of factors known to disrupt brain function, including neuroinflammation and amyloid beta protein. Funding: U.S. Department of Veterans Affairs, and University of Minnesota. Keywords: Healthy brain aging, Human leukocyte antigen, DRB1*13, Apolipoprotein E, Neural network, Magnetoencephalography
ISSN:2352-3964
2352-3964